Vivian T. Thieu

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Julio Rosenstock, Carol Wysham, Juan P. Frías et al. · The Lancet · 2021 · 1K citations

Medicine, Pharmacology, Pharmacotherapy +16

Signal Transducer and Activator of Transcription 4 Is Required for the Transcription Factor T-bet to Promote T Helper 1 Cell-Fate Determination

Vivian T. Thieu, Qing Yu, Hua‐Chen Chang et al. · Immunity · 2008 · 221 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells

Hua-Chen Chang, Shangming Zhang, Vivian T. Thieu et al. · Immunity · 2005 · 156 citations · Full text

Life Sciences, Immunology, Molecular Biology +9

Effect of once‐weekly dulaglutide on glycated haemoglobin ( <scp>HbA1c</scp> ) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline <scp>HbA1c</scp>

Baptist Gallwitz, Samuel Dagogo‐Jack, Vivian T. Thieu et al. · Diabetes Obesity and Metabolism · 2017 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bruton’s Tyrosine Kinase Is Required for TLR-Induced IL-10 Production

Nathan W. Schmidt, Vivian T. Thieu, Brandon A. Mann et al. · The Journal of Immunology · 2006 · 88 citations · Full text

Life Sciences, Immunology, Microbiology +17